Literature DB >> 15279313

Norwegian version of the automatic thoughts questionnaire: a reliability and validity study.

Andrea P Chioqueta1, Tore C Stiles.   

Abstract

This study investigated the reliability and validity of the Norwegian version of the Automatic Thoughts Questionnaire. Three samples were used: (a) 344 male military recruits; (b) 142 psychiatric outpatients; and (c) 41 healthy controls. The Automatic Thoughts Questionnaire was found to have high internal consistency and satisfactory temporal stability. It correlated positively with the Beck Depression Inventory and was found to discriminate significantly between clinically depressed and non-depressed psychiatric patients and healthy controls. In general the results are satisfactory, suggesting that the Norwegian version of the Automatic Thoughts Questionnaire has adequate reliability and validity properties. The Automatic Thoughts Questionnaire was shown to be a useful measure of frequency of automatic negative thoughts in both clinical and non-clinical populations.

Entities:  

Mesh:

Year:  2004        PMID: 15279313     DOI: 10.1080/16506070310016031

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  3 in total

1.  Psychometric properties of the Automatic Thoughts Questionnaire-8 in two Spanish nonclinical samples.

Authors:  Francisco J Ruiz; Miguel A Segura-Vargas; Paula Odriozola-González; Juan C Suárez-Falcón
Journal:  PeerJ       Date:  2020-09-16       Impact factor: 2.984

2.  Examining the stress-burnout relationship: the mediating role of negative thoughts.

Authors:  Ko-Hsin Chang; Frank J H Lu; Theresa Chyi; Ya-Wen Hsu; Shi-Wei Chan; Erica T W Wang
Journal:  PeerJ       Date:  2017-12-19       Impact factor: 2.984

3.  Acceptance and Commitment Therapy preceded by an experimental Attention Bias Modification procedure in recurrent depression: study protocol for a randomized controlled trial.

Authors:  Tom Østergaard; Tobias Lundgren; Robert Zettle; Rune Jonassen; Catherine J Harmer; Tore C Stiles; Nils Inge Landrø; Vegard Øksendal Haaland
Journal:  Trials       Date:  2018-03-27       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.